Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
University of California, San Francisco
The Wellcome Sanger Institute
City of Hope Medical Center
Yonsei University
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Columbia University
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Mayo Clinic
Children's Oncology Group
Mayo Clinic
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University Health Network, Toronto
Mayo Clinic
University of Michigan Rogel Cancer Center
University of Michigan